Richard J. Napolitano - 01 Feb 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role: Chief Accounting Officer
Signature: /s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol: TDOC
Transactions as of: 01 Feb 2022
Net transactions value: -$64,813
Form type: 4
Filing time: 03 Feb 2022, 15:10:28 UTC
Previous filing: 24 Sep 2021
Next filing: 02 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TDOC	Common Stock	Options Exercise		+2,019			2,019	01 Feb 2022	Direct	F1
transaction	TDOC	Common Stock	Sale	$64,813	-824	-41%	$78.66	1,195	02 Feb 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TDOC	Restricted Stock Units	Options Exercise	$0	-2,019	-33%	$0.000000	4,039	01 Feb 2022	Common Stock	2,019		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2	On February 1, 2021, the reporting person was granted 6,058 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F3	Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.